REGULATORY

Scrutinize Purpose of Price Maintenance Premium for New Drugs: MOF

April 28, 2015

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

The Ministry of Finance (MOF) on April 27 called for reexamining the purpose of a key price maintenance premium for on-patent medicines, rapping the premium for being granted merely based on declines in drugs’ market prices and not on their…

To read the full story

MOF Panel Recommends Generic Target of 80% by FY2017-End
June 2, 2015
MOF Presses for 80% Generic Share Target by FY2017
April 28, 2015

REGULATORY

Government Unveils Four-Chapter Outline for 2026 Honebuto
June 26, 2026
LDP, Ishin Leave Chuikyo Reform to Party Negotiators after Talks Stall
June 26, 2026
Japan Targets Global-Level Growth for Domestic Patented Drug Market
June 25, 2026
Paxlovid, Awiqli Braced for NHI Price Cuts after CEAs
June 25, 2026
Drug Pricing to Be Applied to Oncolys Oncolytic Virus Therapy
June 25, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COLUMN

The Psychology of ‘Stuck’: Understanding Why Changing Jobs Feels So Hard

By Philip Carrigan

Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…

COMMENTARY

Adaptation, Diversification Key as Drug Wholesalers Face Profit Squeeze

By Tatsuya Otsuka

Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…